A Systematic Review and Indirect Treatment Comparison of Ferric Carboxymaltose Versus Iron Isomaltoside in Correcting Iron Deficiency Anemia

被引：0

作者：

Chuang, Ling-Hsiang ^{[1
]}

Sun, Wentao ^{[2
]}

Sun, Yujie ^{[2
]}

Han, Bing ^{[3
]}

机构：

[1] Umea Univ, Dept Epidemiol & Global Hlth, Umea, Sweden

[2] Vifor Fresenius Kabi Beijing Pharmaceut Consultin, Beijing, Peoples R China

[3] Beijing Union Med Coll Hosp, Beijing, Peoples R China

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-159364

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2475 / 2476

页数：2

共 50 条

[1] A systematic literature review and indirect comparison of iron isomaltoside and ferric carboxymaltose in iron deficiency anemia after failure or intolerance of oral iron treatment
Pollock, Richard F.
Muduma, Gorden
EXPERT REVIEW OF HEMATOLOGY, 2019, 12 (02) : 129 - 136
[2] A SYSTEMATIC LITERATURE REVIEW AND INDIRECT COMPARISON OF IRON ISOMALTOSIDE AND FERRIC CARBOXYMALTOSE IN IRON DEFICIENCY ANAEMIA AFTER FAILURE OR INTOLERANCE OF ORAL IRON TREATMENT
Pollock, R.
Muduma, G.
VALUE IN HEALTH, 2019, 22 : S374 - S374
[3] Indirect methods of comparison of the safety of ferric derisomaltose, iron sucrose and ferric carboxymaltose in the treatment of iron deficiency anemia
Pollock, Richard F.
Biggar, Patrick
EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (02) : 187 - 195
[4] Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside-a systematic review and meta-analysis
Schaefer, Benedikt
Tobiasch, Moritz
Viveiros, Andre
Tilg, Herbert
Kennedy, Nicholas A.
Wolf, Myles
Zoller, Heinz
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (05) : 2256 - 2273
[5] AN ECONOMIC EVALUATION OF IRON ISOMALTOSIDE 1000 VERSUS FERRIC CARBOXYMALTOSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND IRON DEFICIENCY ANEMIA IN DENMARK
Pollock, R. F.
Muduma, G.
VALUE IN HEALTH, 2018, 21 : S443 - S444
[6] An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark
Richard F. Pollock
Gorden Muduma
Advances in Therapy, 2018, 35 : 2128 - 2137
[7] An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark
Pollock, Richard F.
Muduma, Gorden
ADVANCES IN THERAPY, 2018, 35 (12) : 2128 - 2137
[8] Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
Bernd Froessler
Tijana Gajic
Gustaaf Dekker
Nicolette A. Hodyl
Archives of Gynecology and Obstetrics, 2018, 298 : 75 - 82
[9] Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
Ibrahim A. Abdelazim
Bassam Nusair
Shikanova Svetlana
Gulmira Zhurabekova
Archives of Gynecology and Obstetrics, 2018, 298 : 1231 - 1232
[10] A patient-level cost-effectiveness analysis of iron isomaltoside versus ferric carboxymaltose for the treatment of iron deficiency anemia in the United Kingdom
Pollock, Richard F.
Muduma, Gorden
JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (07) : 751 - 759

← 1 2 3 4 5 →